GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Peptide
Comment: In >10% of solid tumours aberrant Wnt/β-catenin signaling is a recognised driver of resistance to immunotherapy and is associated with poor prognosis. Zolucatetide (FOG-001; Parabilis Medicines) is a cyclic peptide inhibitor of the interaction between β-catenin and the T cell (transcription) factor TCF4 [1]. This action disrupts Wnt signaling, and is proposed for anti-tumour potential. The peptide is highly modified to optimise target engagement and pharmacokinetics.
|
|
Peptide Sequence ![]() |
No information available. |
Download 2D Structure ![]() |
|
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel